The phosphorylation of Hsp20 enhances its association with amyloid-β to increase protection against neuronal cell death

Molecular and Cellular Neuroscience

Volumn 61, Issue , 2014, Pages 46-55

  Cameron, Ryan T ^a   Quinn, Steven D ^b   Cairns, Lynn S ^a   MacLeod, Ruth ^a   Samuel, Ifor D W ^b   Smith, Brian O ^a   Carlos Penedo, J ^b   Baillie, George S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

A oligomerisation; Hsp20; Peptide array

Indexed keywords

AMYLOID BETA PROTEIN; HEAT SHOCK PROTEIN 20; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); ARGININE; PEPTIDE FRAGMENT;

ARTICLE; CONTROLLED STUDY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; CELL DEATH; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MUTATION; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PEPTIDE MAPPING; PHOSPHORYLATION; TIME; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ARGININE; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HSP20 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PHOSPHORYLATION; TIME FACTORS;

EID: 84902244714     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.05.002     Document Type: Article

References (44)

1. Ahmed M., et al. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 2010, 17(5):561-567.
2. Beyreuther K., et al. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome. Prog. Clin. Biol. Res. 1992, 379:159-182.
3. Brownell S.E., Becker R., Steinman L. (The protective and therapeutic function of small heat shock proteins in neurological diseases. Front. Immunol. 2012, 3:74.
4. Datki Z., et al. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull. 2003, 62(3):223-229.
5. Diaz J.C., Linnehan J., Pollard H., Arispe N. Histidines 13 and 14 in the Aβ sequence are targets for inhibition of Alzheimer's disease Aβ ion channel and cytotoxicity. Biol. Res. 2006, 39(3):447-460.
6. Diemert S., et al. (Impedance measurement for real time detection of neuronal cell death. J Neurosci Methods 2012, 203(1):69-77.
7. Edwards H.V., Cameron R.T., Baillie G.S. The emerging role of HSP20 as a multifunctional protective agent. Cell. Signal. 2011, 23(9):1447-1454.
8. Edwards H.V., Scott J.D., Baillie G.S. PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects. Biochem. Soc. Trans. 2012, 40(1):210-214.
9. Edwards H.V., Scott J.D., Baillie G.S. (The A-kinase anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Serine 16. Biochem. J. 2012.
10. Eyles S.J., Gierasch L.M. (Nature's molecular sponges: small heat shock proteins grow into their chaperone roles. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(7):2727-2728.
11. Fan G.C., Kranias E.G. Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure. J. Mol. Cell. Cardiol. 2011, 51(4):574-577.
12. Fan G.C., et al. Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis. Circ. Res. 2004, 94(11):1474-1482.
13. Frank R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 2002, 267(1):13-26.
14. Garai K., Frieden C. (Quantitative analysis of the time course of Abeta oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Abeta. Proc. Natl. Acad. Sci. U.S.A. 2013, 110(9):3321-3326.
15. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356.
16. Harrison R.S., Sharpe P.C., Singh Y., Fairlie D.P. Amyloid peptides and proteins in review. Rev. Physiol. Biochem. Pharmacol. 2007, 159:1-77.
17. Hilbich C., Kisters-Woike B., Reed J., Masters C.L., Beyreuther K. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. J. Mol. Biol. 1992, 228(2):460-473.
18. Inayathullah M., Teplow D.B. Structural dynamics of the DeltaE22 (Osaka) familial Alzheimer's disease-linked amyloid beta-protein. Amyloid 2011, 18(3):98-107.
19. Kudva Y.C., Hiddinga H.J., Butler P.C., Mueske C.S., Eberhardt N.L. Small heat shock proteins inhibit in vitro Abeta(1-42) amyloidogenesis. FEBS Lett. 1997, 416(1):117-121.
20. Kwan A.H., Mobli M., Gooley P.R., King G.F., Mackay J.P. Macromolecular NMR spectroscopy for the non-spectroscopist. FEBS J. 2011, 278(5):687-703.
21. Lambert M.P., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(11):6448-6453.
22. Lee S., Carson K., Rice-Ficht A., Good T. Small heat shock proteins differentially affect Abeta aggregation and toxicity. Biochem. Biophys. Res. Commun. 2006, 347(2):527-533.
23. Levy E., et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248(4959):1124-1126.
24. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J. Neurosci. Methods 2000, 96(2):147-152.
25. Morgan C., Colombres M., Nunez M.T., Inestrosa N.C. Structure and function of amyloid in Alzheimer's disease. Prog. Neurobiol. 2004, 74(6):323-349.
26. Mosse Y.P., et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008, 455(7215):930-935.
27. Mozes E., Hunya A., Posa A., Penke B., Datki Z. (A novel method for the rapid determination of beta-amyloid toxicity on acute hippocampal slices using MTT and LDH assays. Brain Res. Bull. 2012, 87(6):521-525.
28. Nicolaou P., et al. Human mutation in the anti-apoptotic heat shock protein 20 abrogates its cardioprotective effects. J. Biol. Chem. 2008, 283(48):33465-33471.
29. Nilsberth C., et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 2001, 4(9):887-893.
30. 2+. FEBS J. 2009, 276(15):4051-4060.
31. Quinn S.D., et al. Real-time probing of beta-amyloid self-assembly and inhibition using fluorescence self-quenching between neighbouring dyes. Mol. Biosyst. 2014, (in Press).
32. Reitz C. Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int. J. Alzheimer's Dis. 2012, 369808.
33. Selkoe D.J., Podlisny M.B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 2002, 3:67-99.
34. Simmons L.K., et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 1994, 45(3):373-379.
35. Sin Y.Y., et al. (Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the beta-agonist induced hypertrophic response in cardiac myocytes. J. Mol. Cell. Cardiol. 2011, 50(5):872-883.
36. Sticht H., et al. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 1995, 233(1):293-298.
37. Tjernberg L.O., et al. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 1996, 271(15):8545-8548.
38. Watanabe K., et al. Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay. J. Pept. Res. 2001, 58(4):342-346.
39. Wilhelmus M.M., et al. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol. Appl. Neurobiol. 2006, 32(2):119-130.
40. Wilhelmus M.M., et al. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res. 2006, 1089(1):67-78.
41. Wilhelmus M.M., et al. Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion. Neurobiol. Aging 2009, 30(2):229-240.
42. Xiao C., Lachance B., Sunahara G., Luong J.H. An in-depth analysis of electric cell-substrate impedance sensing to study the attachment and spreading of mammalian cells. Anal. Chem. 2002, 74(6):1333-1339.
43. Xiao C., Lachance B., Sunahara G., Luong J.H. Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. Anal. Chem. 2002, 74(22):5748-5753.
44. Zheng H., Koo E.H. The amyloid precursor protein: beyond amyloid. Mol. Neurodegener. 2006, 1:5.